 |
|
|
| |
A higher Fibrosis-4 (FIB-4) score is associated with
higher healthcare costs and hospitalizations in patients
with nonalcoholic steatohepatitis (NASH)
|
| |
| |
EASL 2022 June 22-26 London
E TAPPER 1, J FISHMAN 2, S DODGE 2, K MILLER 2, N ZENG 3, A BOGDANOV 3, M BONAFEDE 3
1 University of Michican, Ann Arbor, MI, USA
2 Madrigal Pharmaceuticals, Conshohocken, PA, USA
3 Veradigm Life Sciences, Chicago, IL, USA
|
| |
|
|
|
|
|
